Efficacy and Toxicity of Docetaxel as a Radiosenstizer in Head and Neck Cancer
Conditions: Head and Neck Cancer Interventions: Drug: Docetaxel Sponsors: Assiut University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Docetaxel | Head and Neck Cancer | Research | Taxotere | Toxicology